REG - IP Group PLC - Notice of Results

IPAnnouncement

10/02/2023 10:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230210:nRSJ5828Pa&default-theme=true

RNS Number : 5828P  IP Group PLC  10 February 2023

 FOR RELEASE ON  10 February 2023

 

IP Group plc - Notice of results

 

IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"),
which develops world-changing science and technology businesses across life
sciences, technology and cleantech, announces that it intends to publish its
annual financial results for the year ended 31 December 2022 on Wednesday 08
March 2023.

 

The results will be available via the London Stock Exchange's Regulatory News
Service (RNS) and on the Investor Relations section of the company's website
at  www.ipgroupplc.com (http://www.ipgroupplc.com/) .

 

Key members of IP Group plc's leadership team will provide a live presentation
via the Investor Meet Company platform on 08 March 2023 at 10:00am BST.

 

Questions can be submitted pre-event via the Investor Meet Company dashboard
up until 9am the day before the meeting or at any time during the live
presentation. Investors can sign up to Investor Meet Company for free via:
https://www.investormeetcompany.com/ip-group-plc/register-investor
(https://www.investormeetcompany.com/ip-group-plc/register-investor) .
Investors who already follow IP Group on the Investor Meet Company platform
will automatically be invited.

 

For more information, please contact:

 

 IP Group plc                                             www.ipgroupplc.com (http://www.ipgroupplc.com)
 Liz Vaughan-Adams, Communications                        +44 (0) 20 7444 0062/+44 (0) 7967 312125
 Portland
 Vic Wallin                                               +44 (0) 7973 823 119
 Alex Donaldson                                           +44 (0) 7516 729 702

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across
life sciences, technology and cleantech (through Kiko Ventures). The Group has
a strong track record of success, having been the founder investor in a number
of high-profile companies including Oxford Nanopore Technologies plc, and has
one of the most exciting portfolios of high-growth businesses in Europe. The
Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs
world-changing technologies emerging from the UK's leading universities and
research institutions. IP Group is listed on the Main Market of the London
Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOREANAEFSLDEEA